- Rejects the ad
- Testosterone, cypionate, enclomiphene, sildenafil or any drug term in ad text, keywords or the landing page
- Claims about energy, muscle, libido or performance outcomes
- Risks the account
- Peptides or other unapproved substances anywhere the ad can reach
- Trademark bidding on drug brands
- Requires
- Nothing, for clinic and treatment intent: online TRT clinic, testosterone therapy online, men's health telehealth, low testosterone treatment clinic
- How we run it
- Phase one runs the open terms with copy about the labs, the prescriber visit, the states served and the monthly program, landing on a page that leads with the process and keeps medication options below the fold.
Google Ads TRT
Google Ads for TRT telehealth: certification, keywords and copy
Short answer
As of September 2026, a TRT telehealth brand can run Google Ads on clinic and treatment intent without certification, and needs LegitScript certification followed by Google's prescription drug services certification before testosterone or any drug term appears in ads, keywords or landing pages. Enclomiphene and peptides stay off the account even after certification because they are not FDA-approved drugs. MedScale Health runs TRT telehealth on Google in that order: open-intent campaigns from week one, drug-term campaigns after certification.
Checked against the platform policy pages on 2026-09-16. By Michael Borgia, MedScale Health.
What this means for you
- Online TRT clinic, testosterone therapy online and TRT telehealth are open keywords today. Testosterone cypionate, TRT prescription online and any drug name are certification-gated.
- Certification is two applications in sequence: LegitScript first, Google second. Budget weeks, not days, and keep the open campaigns running throughout.
- Enclomiphene, hCG for TRT and peptides are unapproved-pharmaceutical terms on Google. They cannot be advertised with or without certification.
- Testosterone is a controlled substance, so landing pages state the prescribing and telemedicine requirements plainly. Google and LegitScript both read for that.
- The conversion is labs ordered or intake completed in a served state, then a prescriber visit. Clicks on drug terms from price-shoppers are excluded by negatives.
Policy reality
What each platform allows for trt and men's health telehealth.
Positions are read from each platform's own policy pages, with the source linked on every row and the date we last checked it. Where a row names a certification it is LegitScript, the third-party certification Meta and Google require before a pharmacy or telehealth provider can promote prescription drugs.
Checked 2026-09-16Full policy tracker
- Rejects the ad
- Presenting compounded testosterone or enclomiphene as FDA-approved
- Outcome claims
- Risks the account
- Losing LegitScript certification, which revokes Google's
- Drifting from telehealth positioning to pharmacy positioning after approval
- Requires
- LegitScript Healthcare Merchant Certification for the telemedicine provider and its domain, then Google's Healthcare and medicines certification filed for prescription drug services with the certified domain and customer ID
- How we run it
- Phase two adds testosterone and TRT-prescription keyword campaigns on the certified domain, with the controlled-substance and telemedicine requirements stated on the page and no unapproved products anywhere in the account.
- Rejects the ad
- "Low T?" personal-attribute hooks
- Drug names without certification and authorization
- Shirtless or idealized-body imagery
- Risks the account
- Pharmacy-style landing pages
- Enclomiphene or peptides as products
- Requires
- LegitScript certification and Meta authorization before naming testosterone; clinic-service ads run without it
- How we run it
- The same lab-first, provider-led offer, aimed 18 and over, with medication named on the page rather than in the ad until authorization is active.
What Google's rules say about testosterone telehealth
Two Google policies decide the category. The prescription drug services rule requires online pharmacies and telemedicine providers to be certified before their ads serve, and the restricted drug terms rule allows prescription drug terms in ads, keywords and landing pages only for certified advertisers, and only in a handful of countries including the United States. For a US telehealth brand that means the open path is clinic and treatment intent with no drug names anywhere the ad touches, and the certified path is the full drug-term auction. Separately, Google's unapproved pharmaceuticals rule blocks enclomiphene and peptides outright, because neither is an FDA-approved drug; certification does not change that. And because testosterone is a controlled substance, Google's reviewers and LegitScript's analysts both look for the prescribing and telemedicine requirements to be stated on the page rather than implied.
Phase one: the keywords that run without certification
The open campaigns are built on intent that describes the service rather than the substance. Clinic intent: online TRT clinic, TRT telehealth, testosterone clinic online. Treatment intent: testosterone therapy online, low testosterone treatment, men's hormone therapy telehealth. Process intent: at-home testosterone test, TRT labs online. State intent where the brand is licensed: TRT telehealth plus state. Ad copy describes the program: at-home or local labs, a video visit with a licensed prescriber, monthly follow-up, states served, and what the first month costs if the brand publishes it. Negative keyword lists exclude every drug name, cypionate, enclomiphene, peptide and price-comparison term so the open campaigns never trip the drug-term rule by accident. Call extensions matter less than in a clinic account; the conversion is the intake, so the landing page and the sitelinks point at it.
Phase two: LegitScript, then Google
Certification is worth it for a TRT telehealth brand because the drug-term auction is where the volume is and because most brands ship medication and need certification for their payment processor anyway. LegitScript's Healthcare Merchant Certification is one application per root domain, with an application fee and an annual fee published on its pricing page, and a review that examines licensing, prescribing practice for a controlled substance, privacy and marketing claims. Answering LegitScript's questions quickly is the single biggest factor in how long it takes. Once approved, Google's Healthcare and medicines certification is a separate online application filed with the customer ID and the certified domain. Only then do testosterone and TRT-prescription keyword campaigns launch, on the certified domain, with landing pages that state the compounding status of any compounded testosterone and the prescriber oversight.
Ad copy and landing pages that clear both reviews
Copy that passes is about the process and the provider: labs, visit, prescription if appropriate, follow-up, price. It avoids second-person claims about the reader's energy or performance, which Google reads as unsubstantiated outcome claims and Meta reads as personal attributes. The landing page leads with the program and the lab panel, explains medication options in a lower section, states the controlled-substance and telemedicine requirements in plain language, names the medical director, and carries the certification seal in the footer once it exists. Enclomiphene and hCG, where the brand offers them, are explained on the page as options discussed with the prescriber, never as products with prices, and peptides are kept off every page an ad can reach. A page built this way satisfies Google's reviewer in phase one and LegitScript's analyst in phase two without being rebuilt.
Measurement and how MedScale Health runs it
The metrics are cost per qualified lead (intake completed in a state the brand serves), labs ordered, prescriber visits booked, prescriptions issued as reported by the intake platform, and ninety-day retention by campaign. The click ID is carried into the intake platform inside a bridge token and each downstream event is sent back server-side with it attached, so the campaign is credited with the patient and no health detail is sent to Google. Week one is the policy read of the account, pages and pixel, with controlled-substance flags listed separately. Week two puts tracking live. Week three launches phase one, and the LegitScript application starts in parallel with the pages already compliant. If the account is currently suspended for drug-term or unapproved-substance reasons, the Ad Account Rescue diagnoses the flag inside twelve hours and rebuilds to policy inside seventy-two.
Google Ads for TRT Telehealth questions
What buyers ask before they book.
Can a TRT telehealth brand run Google Ads without LegitScript?
Yes, on clinic and treatment intent: online TRT clinic, testosterone therapy online, TRT telehealth. The ads, keywords and landing page cannot contain a drug name, and negatives keep drug-term searches out. Certification is needed only for the drug-term auction, and it runs as a second phase while the open campaigns keep the intake full.
Does certification let us advertise enclomiphene?
No. Enclomiphene is not an FDA-approved drug, so it falls under Google's unapproved pharmaceuticals rule regardless of certification, and the same applies to peptides. A brand that offers enclomiphene explains it on the page as an option discussed with the prescriber and never names it in ads, keywords or as a product for sale.
How long does Google certification take for TRT?
LegitScript's review takes weeks and depends on documentation and response speed; expedited review is offered for an additional fee. Google's certification is a separate application after LegitScript approval and is not instant either. Plan for a phase-one period of open-intent campaigns while both run, rather than waiting to advertise until certification lands.
Why does Google flag our testosterone landing page even though our ads are clean?
Google reviews the landing page as part of the ad. A page that names testosterone with a price and an order button reads as a pharmacy, which pulls every ad pointing at it under the prescription-drug rules. Lead with the program and the labs, move medication options below the fold, state the prescribing requirements, and remove anything that reads as a drug for sale.
How do you attribute a prescription that happens in our intake platform?
The click ID travels into the intake platform inside a bridge token, and the visit and prescription events are sent back server-side with that token attached. Google receives a generic conversion with the click ID and no health detail; the brand's report shows cost per qualified lead through prescriptions issued by campaign and state.
From the answers library
The answers behind this page.
Why Are Your Google Ads Disapproved for Telehealth, and How Do You Fix It?
Google disapproves telehealth ads for three recurring reasons: the advertiser is not certified to promote telemedicine or prescription medication, the destination page makes claims the policy treats as unsupported, or the campaign promotes a substance Google restricts outright. MedScale, a growth agency working exclusively with telehealth brands, checks certification status first, because an uncertified account keeps failing review no matter how carefully the creative is written.
Reviewed September 16, 2026
Who Needs LegitScript Certification to Advertise Telemedicine?
Advertisers promoting telemedicine services or prescription medication on Google, and on several other major platforms, generally need LegitScript certification before their ads will serve in the United States. MedScale, which builds patient acquisition for telehealth companies exclusively, treats certification as a launch dependency rather than a compliance afterthought, because campaigns planned around an uncertified account simply will not deliver.
Reviewed August 3, 2026
How Do You Run Google Ads for a GLP-1 Telehealth Brand?
Google gates this category at the advertiser level rather than the creative level, so certification comes first and everything else follows from it. MedScale, which works exclusively with telehealth brands, sequences GLP-1 search programmes in that order: establish certification, build landing pages that survive policy review, then expand keywords, because scaling an uncertified or poorly landed account simply produces disapprovals at greater volume.
Reviewed August 3, 2026
Research Peptides vs Prescribed Peptides: Which Carries More Advertising Risk?
Research positioning does not reduce advertising risk, it relocates it. Selling under a not-for-human-consumption framing while operating a consumer funnel creates a mismatch between the stated purpose and the actual one, which platforms treat as misrepresentation. MedScale, a growth agency working exclusively with telehealth brands, considers the prescribed route the more defensible position commercially as well as legally, despite being the more constrained one.
Reviewed September 16, 2026
Next step
Start with the audit.
We read your live ads, landing pages and tracking against the rules on this page and send back the flags and a written ninety-day plan in five business days. If the account is already restricted, the rescue is the faster door.
Growth audit
See where your growth is leaking.
We audit the funnel, the tracking, and the compliance posture, then hand you the roadmap. The people writing it have run the same funnel from the inside. You keep it whether or not we work together.
- Reviewed
- Funnel, tracking, and compliance posture
- Discussed
- One 30-minute call with the operator on your account
- Delivered
- A written roadmap within 5 business days